MX2021001867A - Administracion y monitoreo de oxidio nitrico en fluidos ex vivo. - Google Patents

Administracion y monitoreo de oxidio nitrico en fluidos ex vivo.

Info

Publication number
MX2021001867A
MX2021001867A MX2021001867A MX2021001867A MX2021001867A MX 2021001867 A MX2021001867 A MX 2021001867A MX 2021001867 A MX2021001867 A MX 2021001867A MX 2021001867 A MX2021001867 A MX 2021001867A MX 2021001867 A MX2021001867 A MX 2021001867A
Authority
MX
Mexico
Prior art keywords
nitric oxide
administration
monitoring
fluids
fluid
Prior art date
Application number
MX2021001867A
Other languages
English (en)
Inventor
Jim Potenziano
Douglas R Hansell
Jeff Griebel
Eddie Costa
Lisa Cooper
Original Assignee
Mallinckrodt Hospital Products Ip Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Hospital Products Ip Ltd filed Critical Mallinckrodt Hospital Products Ip Ltd
Publication of MX2021001867A publication Critical patent/MX2021001867A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0236—Mechanical aspects
    • A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
    • A01N1/0247—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components for perfusion, i.e. for circulating fluid through organs, blood vessels or other living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3623—Means for actively controlling temperature of blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Thermal Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a sistemas y métodos para monitorear la administración de óxido nítrico (NO) a fluidos ex vivo. Ejemplos de tales fluidos incluyen sangre en los circuitos de oxigenación de membrana extracorporal (ECMO) o fluidos de perfusión usados para preservar órganos ex vivo previo al transplante en un recipiente. Los sistemas y métodos descritos en la presente se proporcionan para administrar óxido nítrico al fluido, monitorear óxido nítrico o un marcador de óxido nítrico en el fluido, y ajustar la administración de óxido nítrico.
MX2021001867A 2013-03-15 2016-05-31 Administracion y monitoreo de oxidio nitrico en fluidos ex vivo. MX2021001867A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361787865P 2013-03-15 2013-03-15
US14/095,621 US9629358B2 (en) 2013-03-15 2013-12-03 Administration and monitoring of nitric oxide in ex vivo fluids

Publications (1)

Publication Number Publication Date
MX2021001867A true MX2021001867A (es) 2021-04-19

Family

ID=51528684

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016007057A MX2016007057A (es) 2013-03-15 2014-12-01 Administracion y monitoreo de oxido nitrico en fluidos ex vivo.
MX2021001867A MX2021001867A (es) 2013-03-15 2016-05-31 Administracion y monitoreo de oxidio nitrico en fluidos ex vivo.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016007057A MX2016007057A (es) 2013-03-15 2014-12-01 Administracion y monitoreo de oxido nitrico en fluidos ex vivo.

Country Status (11)

Country Link
US (3) US9629358B2 (es)
EP (2) EP3698630B1 (es)
JP (2) JP6612231B2 (es)
AU (3) AU2014357412B2 (es)
CA (3) CA2931943C (es)
DK (1) DK3698630T3 (es)
ES (1) ES2805366T3 (es)
FI (1) FI3698630T3 (es)
MX (2) MX2016007057A (es)
PT (1) PT3698630T (es)
WO (1) WO2015084698A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
JP6029650B2 (ja) 2011-04-14 2016-11-24 トランスメディクス，インコーポレイテッド ドナー肺のＥｘ−ｖｉｖｏにおける機械的灌流のための臓器保護溶液
CA2950759C (en) 2014-06-02 2023-02-21 Transmedics, Inc. Ex vivo organ care system
CN106998676B (zh) 2014-12-12 2021-10-26 体沃索股份有限公司 用于器官灌注的装置和方法
JP2019501965A (ja) * 2015-12-11 2019-01-24 ベロ バイオテック エルエルシー 一酸化窒素を含むガスを投与するための方法及び装置
US11202899B2 (en) * 2016-02-12 2021-12-21 Mallinckrodt Pharmaceuticals Ireland Limited Use and monitoring of inhaled nitric oxide with left ventricular assist devices
BR112018074537B1 (pt) 2016-05-30 2023-04-11 Tevosol, Inc Método de ventilar um pulmão extraído
CA3036361A1 (en) * 2016-09-10 2018-03-15 Vero Biotech LLC System and method for portable nitric oxide delivery
TWI656890B (zh) * 2017-07-12 2019-04-21 英屬開曼群島商怡忠國際有限公司 體外生命支持系統
US11044904B2 (en) 2017-08-25 2021-06-29 Mallinckrodt Hospital Products IP Limited Methods to improve organ viability
US11881119B2 (en) * 2017-12-06 2024-01-23 Cilag Gmbh International Modeling air leaks in lungs
GB2587350B (en) * 2019-09-23 2021-12-15 Royal Papworth Hospital Nhs Found Trust Organ perfusion system and method
GB2596041A (en) * 2020-03-26 2021-12-22 Univ Newcastle System and Method for Monitoring Body Tissue
CN113797404B (zh) * 2021-01-06 2023-05-09 郝云玲 一种向血液中补充一氧化氮（no）的装置
EP4137170A1 (en) 2021-07-29 2023-02-22 Tim Bast Purge fluid generator for membrane oxygenation
CN113975505B (zh) * 2021-11-08 2023-12-19 中山大学中山眼科中心 用于眼球灌注的体外循环系统

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338662A (en) 1992-09-21 1994-08-16 Bio-Preserve Medical Corporation Organ perfusion device
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
US5725492A (en) * 1996-03-04 1998-03-10 Cormedics Corp Extracorporeal circulation apparatus and method
EP1712226A3 (en) * 1996-04-05 2007-03-21 The General Hospital Corporation Treatment of a Hemoglobinopathy
US5752504A (en) 1996-12-13 1998-05-19 Ohmeda Inc. System for monitoring therapy during calibration
US5732693A (en) 1996-10-02 1998-03-31 Ohmeda Inc. Pause control of nitric oxide therapy
US5885842A (en) * 1996-11-08 1999-03-23 Medinox, Inc. Methods for the detection of nitric oxide in fluid media
US6125846A (en) 1997-05-16 2000-10-03 Datex-Ohmeda, Inc. Purge system for nitric oxide administration apparatus
US7749693B2 (en) * 1998-09-29 2010-07-06 Lifeline Scientific, Inc. Method of determining that an organ is not suitable for transplantation and using it for testing substances
GB9908335D0 (en) * 1999-04-12 1999-06-09 Univ Cambridge Tech Methods and means for extracorporeal organ perfusion
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
JP4258908B2 (ja) * 1999-09-14 2009-04-30 株式会社ジェイ・エム・エス 人工肺装置
JP2001178817A (ja) * 1999-12-24 2001-07-03 Terumo Corp 人工腎臓用装置およびこれを用いた品質評価装置ならびに流体回路
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6501974B2 (en) * 2001-01-22 2002-12-31 Datex-Ohmeda, Inc. Compensation of human variability in pulse oximetry
HUP0400371A3 (en) 2001-06-21 2010-06-28 Beth Israel Hospital Use of carbon monoxide for preparation of pharmaceutical composition available for improving survival or function of organ following transplantation
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US20040081580A1 (en) * 2002-09-10 2004-04-29 Doug Hole Use of nitric oxide and a device in the therapeutic management of pathogens in mammals
US7274955B2 (en) * 2002-09-25 2007-09-25 Masimo Corporation Parameter compensated pulse oximeter
JP4352315B2 (ja) * 2002-10-31 2009-10-28 日本光電工業株式会社 信号処理方法／装置及びそれを用いたパルスフォトメータ
US7485324B2 (en) * 2003-09-29 2009-02-03 Pulmonox Technologies Corporation Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
JP2007523900A (ja) 2004-02-09 2007-08-23 ノクシライザー，インコーポレイテッド 一酸化窒素放出分子
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
IL301141A (en) 2006-04-19 2023-05-01 Transmedics Inc Systems and methods for extracorporeal organ treatment
US9814230B2 (en) * 2008-01-31 2017-11-14 Transmedics, Inc. Systems and methods for ex vivo lung care
EP2385803B1 (en) * 2008-12-31 2013-08-21 Koninklijke Philips Electronics N.V. Apparatus for controlling a light therapy of injury
US9216198B2 (en) 2009-03-30 2015-12-22 The Board Of Regents, The University Of Texas System Compositions and medical devices for controlled release of nitric oxide and methods of production thereof
CA3130908A1 (en) 2009-06-30 2010-12-30 Mallinckrodt Hospital Products IP Limited Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US20120201906A1 (en) 2009-09-08 2012-08-09 Reynolds James D Novel medical uses for no and no donor compounds
NZ707513A (en) 2011-01-06 2016-10-28 Ino Therapeutics Llc Gas delivery device and system
MX362813B (es) 2011-11-07 2019-02-08 Mallinckrodt Hospital Products Ip Ltd Aparato y metodo para vigilar el suministro de oxido nitrico.
EP2854894A1 (en) * 2012-05-31 2015-04-08 Ino Therapeutics LLC Methods of administering nitric oxide to arterial or arterialized blood
CA2905439A1 (en) * 2013-03-13 2014-10-02 Ino Therapeutics Llc Devices and methods for monitoring oxygenation during treatment with delivery of nitric oxide

Also Published As

Publication number Publication date
AU2018203630A1 (en) 2018-06-21
US11291202B2 (en) 2022-04-05
US20140272920A1 (en) 2014-09-18
WO2015084698A3 (en) 2015-11-05
MX2016007057A (es) 2017-02-02
CA3135254A1 (en) 2015-06-11
CA2931943A1 (en) 2015-06-11
EP3698630A1 (en) 2020-08-26
US20150093738A1 (en) 2015-04-02
US20170215411A1 (en) 2017-08-03
JP2017503762A (ja) 2017-02-02
FI3698630T3 (fi) 2024-05-24
CA3135254C (en) 2024-05-14
ES2805366T3 (es) 2021-02-11
AU2019246828A1 (en) 2019-11-07
EP3086638A2 (en) 2016-11-02
US9629358B2 (en) 2017-04-25
WO2015084698A2 (en) 2015-06-11
JP6612231B2 (ja) 2019-11-27
CA2931943C (en) 2021-11-30
JP6884190B2 (ja) 2021-06-09
EP3698630B1 (en) 2024-03-13
CA3233961A1 (en) 2015-06-11
AU2018203630B2 (en) 2019-08-29
AU2019246828B2 (en) 2021-12-02
DK3698630T3 (da) 2024-05-21
AU2014357412A1 (en) 2016-06-16
EP3086638B1 (en) 2020-04-22
AU2014357412B2 (en) 2018-03-01
JP2020033368A (ja) 2020-03-05
PT3698630T (pt) 2024-05-31

Similar Documents

Publication Publication Date Title
MX2021001867A (es) Administracion y monitoreo de oxidio nitrico en fluidos ex vivo.
CR20160104A (es) Dispositivo de estabilización de conexión de catéter y procedimientos de uso del mismo
MX2023000378A (es) Kits, dispositivos descartables para reducir el oxigeno y metodos para usarlos.
AU2018253574A1 (en) Irrigated catheter with fluid evacuation
CA2902713C (en) Method and apparatus for drug delivery to a target site
WO2014160804A3 (en) Systems and methods using microneedles
MX2013005393A (es) Dispositivos y metodos para formar una fistula.
TR201818927T4 (tr) Kataterlerde İyileştirme
TR201905882T4 (tr) Dağıtım aparatı.
BR112016028510A2 (pt) dispositivo de aplicação de agente terapêutico com lúmen convergente
MX2016009379A (es) Adaptador de cateter con compuerta con retencion de accionador de septo integrado.
GB2526459A (en) In line fluid sampling port
EA201491713A1 (ru) Обеспечивающий инъекции порт сосудистого доступа с различимыми метками для идентификации
WO2015135955A8 (en) Surgical procedure and devices for use therein
WO2010140150A3 (en) Arterial device, system and method
BR112016010103A8 (pt) métodos, kits e dispositivos de suprimento de fármaco osmótico.
BR112015022055A2 (pt) gestão de transições de área de cuidado de infusões intravenosas
MX2015001508A (es) El uso de antitrombina en la oxigenacion por membrana extracorporea.
CO2018000768A2 (es) Administración intravenosa de citrulina durante la cirugía
MX2018006226A (es) Agente estimulador del receptor 1b de 5-hidroxitriptamina para mejorar el potencial de injerto in vivo.
MY177473A (en) Agent for elevating nitric oxide concentration
TN2016000083A1 (en) Methods and tools relating to the administration of contrast medium
EP2997992A4 (en) Mechanism for guiding and/or releasing an endoprosthesis at a blood vessel lesion region, used in a medical device of the type of a cathether
WO2015054208A8 (en) Injectable compositions
WO2015061801A3 (en) System, apparatus, and method for creating a lumen